Hussman Strategic Advisors’s Amneal Pharmaceuticals AMRX Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | – | Sell |
-210,000
| Closed | -$1.76M | – | 217 |
|
|
2025
Q1 | $1.76M | Sell |
210,000
-42,000
| -17% | -$352K | 0.43% | 92 |
|
|
2024
Q4 | $2M | Buy |
252,000
+42,000
| +20% | +$333K | 0.59% | 63 |
|
|
2024
Q3 | $1.75M | Buy |
210,000
+63,000
| +43% | +$524K | 0.43% | 108 |
|
|
2024
Q2 | $933K | Buy |
+147,000
| New | +$933K | 0.26% | 148 |
|
|
2023
Q2 | – | Sell |
-180,000
| Closed | -$250K | – | 296 |
|
|
2023
Q1 | $250K | Hold |
180,000
| – | – | 0.04% | 292 |
|
|
2022
Q4 | $358K | Hold |
180,000
| – | – | 0.06% | 271 |
|
|
2022
Q3 | $364K | Hold |
180,000
| – | – | 0.06% | 264 |
|
|
2022
Q2 | $572K | Hold |
180,000
| – | – | 0.1% | 250 |
|
|
2022
Q1 | $751K | Hold |
180,000
| – | – | 0.15% | 210 |
|
|
2021
Q4 | $862K | Hold |
180,000
| – | – | 0.19% | 173 |
|
|
2021
Q3 | $961K | Hold |
180,000
| – | – | 0.21% | 163 |
|
|
2021
Q2 | $922K | Hold |
180,000
| – | – | 0.19% | 191 |
|
|
2021
Q1 | $1.21M | Buy |
180,000
+57,000
| +46% | +$383K | 0.25% | 158 |
|
|
2020
Q4 | $562K | Buy |
123,000
+21,000
| +21% | +$96K | 0.15% | 221 |
|
|
2020
Q3 | $396K | Buy |
+102,000
| New | +$396K | 0.1% | 225 |
|
|
2018
Q4 | – | Sell |
-125,000
| Closed | -$2.77M | – | 264 |
|
|
2018
Q3 | $2.77M | Sell |
125,000
-75,000
| -38% | -$1.66M | 0.8% | 41 |
|
|
2018
Q2 | $3.28M | Buy |
+200,000
| New | +$3.28M | 0.88% | 34 |
|